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and Emrush Rexhaja,Purpose of review
To provide an overview of available evidence of the potential role of epigenetics in the pathogenesis of
hypertension and vascular dysfunction.
Recent findings
Arterial hypertension is a highly heritable condition. Surprisingly, however, genetic variants only explain a
tiny fraction of the phenotypic variation and the term ‘missing heritability’ has been coined to describe this
phenomenon. Recent evidence suggests that phenotypic alteration that is unrelated to changes in DNA
sequence (thereby escaping detection by classic genetic methodology) offers a potential explanation. Here,
we present some basic information on epigenetics and review recent work consistent with the hypothesis of
epigenetically induced arterial hypertension.
Summary
New technologies that enable the rigorous assessment of epigenetic changes and their phenotypic
consequences may provide the basis for explaining the missing heritability of arterial hypertension and
offer new possibilities for treatment and/or prevention.
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DOI:10.1097/HCO.0000000000000192Hypertension is defined as a condition with a SBP at
least 140mm Hg or a DBP at least 90mm Hg, it
affectsmore than 1 billion peopleworldwide, and its
cost makes up an important part of the healthcare
expenses in industrialized countries [1]. Hyperten-
sion is the most prevalent cardiovascular risk factor
worldwide [2]. Although in approximately 10% of
hypertensive patients an underlying cause can be
identified, in the remaining 90% the cause of high
blood pressure remains unknown, and the term
‘essential hypertension’ has been coined to describe
this condition. There is abundant evidence that
essential hypertension is a highly heritable con-
dition, and heritability of hypertension has been
estimated at between 30 and 40% [3,4]. In line with
this concept, large genome-wide linkage and associ-
ation studies have identified many novel genetic
variants associated with increased arterial blood
pressure, unmistakably demonstrating the multi-
genic complexity of essential hypertension. Surpris-
ingly, however, these genetic variants, individually
and collectively, only explain a tiny fraction of
phenotypic variation and disease risk [1]. Of note,
though, similar differences between estimated andht © 2015 Wolters Kluwe
rs Kluwer Health, Inc. All rights reseassociation studies of other complex diseases in
humans, and the term ‘missing heritability’ has
been coined to describe this difference. Accordingly,
in research on hypertension (and other complex
diseases), the search for missing heritability has
emerged as a major goal.
Although several possibilities such as unex-
plored portions of the genome, gene interactions,
or untested genetic variants, to name just a few,
have been suggested [5,6], phenotypic alteration,r Health, Inc. All rights reserved.
rved. www.co-cardiology.com
KEY POINTS
 Although a highly heritable trait, the pathogenesis of
essential hypertension is poorly understood.
 Genetic variants account for only a small proportion of
blood pressure variation.
 The concept of missed heritability is defined as the
difference between estimated and observed variance.
 Fetal programming and epigenetic alterations may
importantly contribute to explain this phenomenon.
Hypertensionwhich is unrelated to changes in DNA sequence and
thereby is not detected using classic genetic meth-
odology, offers an attractive hypothesis. In line with
this hypothesis, there is emerging evidence demon-
strating epigenetic alteration of genes affecting
important pathways in blood pressure regulation
[7,8] that, if heritable, could provide the scientific
basis explaining part of the missing heritability in
essential hypertension. Here, we will briefly present
some basic information on epigenetics and then
review recent studies in experimental animal
models and humans consistent with the concept
of epigenetically induced arterial hypertension.FETAL PROGRAMMING OF ADULT
DISEASE HYPOTHESIS
Epidemiological data suggest that environmental
factors acting during the fetal and perinatal period
alter the regulation of cardiovascular and metabolic
homeostasis, which predisposes to cardiovascular
and/or metabolic disease later in life. These obser-
vations have led to the so-called ‘fetal programming
of adult disease hypothesis’ or ‘Barker hypothesis’
[9]. This hypothesis suggests that pathological
events during embryonic, fetal, and early postnatal Copyright © 2015 Wolters Kluwer 
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metabolic homeostasis, and thereby increase the
risk for cardiovascular disease and diabetes later in
life (Fig. 1). Although most evidence for fetal pro-
gramming stems from epidemiological studies in
humans and experimental work in mammals, there
is also evidence for fetal programming and its inter-
generational transmission in lower organisms, such
as the fruit fly Drosophila melanogaster [10]. For
example, in humans, maternal malnutrition during
early gestation (Dutch famine studies) increases the
prevalence of coronary heart disease in the offspring
[11]. In line with these observations in humans,
maternal diet restriction during pregnancy in
rodents, an experimental model mimicking pre-
eclampsia in humans, induces systemic and pul-
monary hypertension in the offspring, which
appears to be related to an epigenetic mechanism
[8,12].EPIGENETICS
Epigenetics is defined as the transmission of gene
expression patterns from one cell generation to the
next, which do not rely on differences in DNA
sequence. There exist many examples of cell func-
tions (e.g., tissue specificity, X-chromatin inacti-
vation, germline specificity) that are critically
dependent on epigenetic control of gene expression.
Technological progress that allows epigenetic profil-
ing across the genome has allowed documenting in
experimental animals that epigenetic modifications
take place not only during early development but
also later in life [13,14]. The term ‘epigenetics’ refers
to chromatin-based mechanisms that regulate gene
expression without affecting the DNA sequence per
se. Although epigenetic changes may take place
throughout life, the most important epigenetic
modifications take place during embryonic, fetal,
and early postnatal development. These epigeneticHealth, Inc. All rights reserved.
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Fetal programming and epigenetic mechanisms in arterial hypertension Scherrer et al.mechanisms are essential for the adequate regula-
tion of gene expression during these different phases
of early life. The important activity of the epi-
genome during early life also renders it particularly
vulnerable. In line with this concept, there is
increasing data indicating that during early life,
epigenetic mechanisms are strongly influenced by
the environment [15
&
] and that environmentally
induced epigenetic modifications are heritable
throughout generations. The latter is related to
the fact that epigenetic changes not only affect
the phenotype of the immediate offspring, but,
because some of these changes are not erased during
gametogenesis, also affect the phenotype and health
of future generations. It is remarkable that epige-
netic inheritance of premature vascular ageing and
arterial hypertension in mice generated by in-vitro
fertilization appears as strong as conventional
genetic effects observed in knockout animal models
[8].
The best-studied epigenetic mechanisms
involve DNA methylation and histone modifi-
cations (acetylation and deacetylation; Fig. 2). Other
mechanisms, such as micro-RNAs, have also been
described [1].ROLE OF EPIGENETICS IN HYPERTENSION
Arterial hypertension and premature vascular
ageing induced by in-vitro fertilization
Assisted reproductive technologies (ART), which
initially were developed to treat women with tubal Copyright © 2015 Wolters Kluwe
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FIGURE 2. Epigenetic mechanisms of gene regulation. Fetal/p
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0268-4705 Copyright  2015 Wolters Kluwer Health, Inc. All rights resedisease, have been applied to an ever expanding list
of other situations, resulting in an exponential
growth of the number of babies born by this
procedure, who now account for 2–5% of births
in developed countries [16]. Based on emerging data
showing that the early embryo is particularly sensi-
tive to environmental insults, we speculated that
ART alters cardiovascular function in the offspring.
In line with this speculation, we found that young,
apparently healthy ART children display signs of
premature vascular ageing of the systemic circula-
tion together with pulmonary vascular dysfunction
predisposing to exaggerated hypoxic pulmonary
hypertension [17–20]. Most importantly, recent
data indicate that ART-induced vascular dysfunc-
tion translates into increased arterial blood pressure.
Ceelen et al. [21] reported higher systolic and dias-
tolic office blood pressure in ART children than in
spontaneously conceived control children, and pre-
liminary data using 24-h ambulatory blood pressure
measurements show that in ART children, vascular
dysfunction is associated with increased SBP and
DBP compared with control children [22]. These
differences in blood pressure between ART and con-
trol children are clinically important, as childhood
blood pressure tracks into later life [23]. Parentheti-
cally, it is well known that arterial hypertension is
often associated with insulin resistance [24], and
defective nitric oxide-dependent insulin stimu-
lation of blood flow and substrate delivery to
skeletal muscle tissue, which leads to insulin resist-
ance in experimental animal models and humans,
may represent an underlyingmechanism [20,25,26].r Health, Inc. All rights reserved.
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HypertensionAccordingly, a recent study demonstrated insulin
resistance in young adults conceived by ART [27],
suggesting that ART-induced vascular dysfunction
may facilitate diabetes later in life.Epigenetic mechanisms contribute to
assisted reproductive technologies-induced
arterial hypertension and premature
vascular ageing
Consistently with observations in humans, ART
induces arterial hypertension and premature vascu-
lar ageing in mice [8,28
&
]. Most importantly, obser-
vations in ART mice provide direct evidence for the
importance of ART-induced epigenetic alterations
underpinning the cardiovascular alterations. The
evidence is as follows. In ARTmice, the methylation
of the promoter of the gene coding for endothelial
nitric oxide synthase (eNOS) is altered in the aorta.
These epigenetic alterations in the vasculature have
important consequences, as shown by decreased
vascular eNOS and eNOS mRNA expression and
lower nitric oxide plasma concentration in ART
than in control mice [29]. The functional import-
ance of these epigenetic alterations is further dem-
onstrated by the effects of histone deacetylase
inhibitor administration to ART mice. These drugs
have been shown to reverse epigenetic and pheno-
typic changes induced by pathologic events during
early life and to prevent transmission of these
changes to the progeny [29,30]. Consistently with
these observations, butyrate administration to adult
male ART mice normalizes the methylation and
expression of the eNOS gene in vascular tissue
together with vascular responsiveness to acetyl-
choline and prevents the transmission of these alter-
ations to the progeny [29,30].
Collectively, these findings indicate that in
mice, ART alters the cardiovascular phenotype by
an epigenetic mechanism, which changes the entire
chain of events starting from altered eNOS methyl-
ation in the vasculature over endothelial dysfunc-
tion and premature vascular senescence to arterial
hypertension and possibly prematuremortality [29].
It is tempting to speculate that ART-induced epi-
genetic alterations also play a role in ART-induced
premature vascular ageing and arterial hypertension
in humans.Arterial hypertension and premature vascular
ageing in offspring of preeclampsia
Preeclampsia is characterized by hypertension,
proteinuria, and edema, and complicates up to
10% of pregnancies in Western countries. Recent
data in young, apparently healthy offspring of Copyright © 2015 Wolters Kluwer 
396 www.co-cardiology.compreeclampsia demonstrate premature vascular age-
ing of the systemic circulation and exaggerated
hypoxic pulmonary vasoconstriction that are
related to preeclampsia per se rather than to a genetic
abnormality that predisposes the mother to pree-
clampsia and the offspring to vascular dysfunction
[31,32]. These vascular alterations are clinically
important, because they are associated with a
marked increase of the risk for stroke later in life
[33].
Epigenetic mechanism. To test for underlying
mechanisms, we studied offspring of restrictive diet
pregnancy (RDP) in mice, a mouse model mimick-
ing several aspects of preeclampsia in humans [34].
We found that in addition to systemic vascular
dysfunction and arterial hypertension [22], endo-
thelium-dependent pulmonary artery vasodilation
in vitrowas impaired, and hypoxia-induced pulmon-
ary hypertension and right ventricular hypertrophy
in vivo were exaggerated in offspring of RDP
compared with control mice. Most importantly,
pulmonary vascular dysfunction was associated
with altered lung DNAmethylation. Administration
of histone deacetylase inhibitors to offspring of
RDP normalized pulmonary DNA methylation and
pulmonary vascular function, demonstrating the
importance of epigenetic alterations in causing
vascular dysfunction in this model. We speculate
that epigenetic alterations also underpin vascular
dysfunction in offspring of preeclampsia in humans.CONCLUSION
Essential hypertension still remains poorly under-
stood. Hypertension is a highly heritable trait, but
discovered genetic variants account for only a very
small fraction of phenotypic variation. Missing her-
itability, which is the difference between estimated
and observed variance, has become a major goal for
research on hypertension. Here we provide evidence
that epigenetic alterations may contribute impor-
tantly to this problem. New technologies that ena-
ble the rigorous assessment of epigenetic changes
and its phenotypic consequences may provide
the basis for explaining the missing heritability of
arterial hypertension and offer new possibilities for
treatment and/or prevention.Acknowledgements
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